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PCARDIAC SURGERY
Late Outcomes Following Freestyle
Versus Homograft Aortic Root Replacement
Results From a Prospective Randomized Trial
Ismail El-Hamamsy, MD,* Lucy Clark, PHD,* Louis M. Stevens, MD,† Zubair Sarang, BSC,*
Giovanni Melina, MD,* Johanna J. M. Takkenberg, MD, PHD,‡ Magdi H. Yacoub, MD*
London, United Kingdom; Boston, Massachusetts; and Rotterdam, the Netherlands
Objectives The aims of this study were to compare long-term results after homograft versus Freestyle (Medtronic Inc.,
Minneapolis, Minnesota) aortic root replacement.
Background The ideal substitute for aortic root replacement remains undetermined.
Methods Between 1997 and 2005, 166 patients (age 65  8 years) undergoing total aortic root replacement were ran-
domized to receive a homograft (n  76) or a Freestyle bioprosthesis (n  90). Six patients randomly assigned
to homograft crossed over to Freestyle because of unavailability of suitably sized homografts. Median follow-up
was 7.6 years (maximum 11 years; 1,035 patient-years). “Evolving” aortic valve dysfunction was defined as aor-
tic regurgitation 2/4 and/or peak gradient 20 mm Hg.
Results Patient characteristics were comparable between groups. Concomitant procedures were performed in 44% and
47% of Freestyle and homograft patients, respectively (p  0.5). Overall hospital mortality was 4.8% (1% for
isolated root replacement). Eight-year survival was 80  5% in the Freestyle group versus 77  6% in the ho-
mograft group (p  0.9). Freedom from need for reoperation at 8 years was significantly higher after Freestyle
root replacement (100  0% vs. 90  5% after homograft replacement; p  0.02). All reoperations were sec-
ondary to structural valve deterioration (n  6). At last echocardiographic follow-up, actuarial freedom from
evolving aortic valve dysfunction was 86  5% for Freestyle bioprostheses versus 37  7% for homografts
(p  0.001). Clinically, freedom from New York Heart Association functional class III to IV and freedom from
valve-related complications were similar between groups (p  0.7 and p  0.9, respectively).
Conclusions In this patient group, late survival is similar after homograft versus Freestyle root replacement. However, Free-
style aortic root replacement is associated with significantly less progressive aortic valve dysfunction and a lower
need for reoperations. (J Am Coll Cardiol 2010;55:368–76) © 2010 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.09.030w
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she number of patients requiring aortic valve (AV) surgery is
onstantly increasing and is expected to triple within the next
0 years (1). Yet, the ideal AV substitute remains undeter-
ined, in large part due to the scarcity of prospective random-
zed studies comparing different surgical options.
rom the *Department of Cardiac Surgery, Harefield and Royal Brompton NHS
rust, National Heart and Lung Institute, Imperial College London, London, United
ingdom; †Harvard School of Public Health, Harvard University, Boston, Massa-
husetts; and the ‡Department of Cardiothoracic Surgery, Erasmus University
edical Center, Rotterdam, the Netherlands. This study was partly funded by an
cademic grant from Medtronic to the Harefield Heart Science Center. None of the
uthors have received any consultancy fees or hold any financial interests in the
ompany. Dr. El-Hamamsy is supported by a Fellowship Award from the Canadian
nstitute of Health Research and by the Magdi Yacoub Institute. Dr. Stevens is
upported by a Fellowship Award from the Canadian Institute of Health Research.b
Manuscript received May 26, 2009; revised manuscript received September 28,
009, accepted September 30, 2009.Aortic homografts have been used for several decades
ith good long-term results, particularly when implanted as
reestanding aortic roots (2,3). In comparison with more
bstructive prostheses, their lower transvalvular gradients
re associated with better left ventricular mass regression
4). They also show good resistance to infection and other
alve-related complications (2,5). However, in part because
f low-grade immunological mechanisms, homografts can
See page 377
ndergo late degeneration marked by heavy calcification and
alve dysfunction. This finding coupled with limited avail-
bility of homografts has stimulated the search for other
ubstitutes with a similar hemodynamic profile and equal or
etter durability.
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369JACC Vol. 55, No. 4, 2010 El-Hamamsy et al.
January 26, 2010:368–76 Freestyle Versus Homograft Aortic Root ReplacementXenograft stentless aortic bioprosthetic roots, such as the
edtronic Freestyle bioprosthesis (Medtronic Inc., Minne-
polis, Minnesota), were introduced into clinical use almost
decades ago. Freestyle prostheses are porcine roots treated
ith alpha-oleic acid, an anticalcification agent, in an
ttempt to reduce long-term valve degeneration. Freestyle
alves are readily available in different sizes and if shown to
ave good performance, would offer huge potential for
atients requiring aortic root replacement. The objective of
his study was, therefore, to compare outcomes after Free-
tyle versus homograft root replacement in a prospective
andomized trial. We have previously reported the shorter-
erm results showing similar survival, valve performance,
nd functional status between the 2 groups (6). The purpose
f this report was to further analyze the long-term survival,
reedom from reoperation, and valvular and ventricular
erformance after Freestyle versus homograft root
eplacement.
ethods
atient population. From 1997 to 2005, 166 patients were
rospectively randomly allocated to undergo total aortic root
eplacement using a homograft (n  76) or a Medtronic
reestyle aortic root prosthesis (n  90). Six patients from
he homograft group crossed over to the Freestyle group in
he operating room because of the unavailability of a suitably
ized homograft. Patients were analyzed according to allo-
ated treatment. All patients consented to the study, which
as approved by the ethics committee.
All patients 40 years of age requiring AV surgery were
onsidered candidates for this study. Previous surgery, active
ndocarditis, or the need for concomitant procedures did
ot preclude enrollment in the study. Patients with a known
ystemic illness affecting long-term survival and patients
40 years of age were excluded from the study. Median
ollow-up of the patients was 7.6 years (range 0.5 to 10.8
ears; 1,035 patient-years). Completeness of clinical
ollow-up was 87% in the homograft cohort and 88% in the
reestyle cohort (7). Echocardiographic follow-up within
8 months of study closure, redo operation, or death was
3% complete in the homograft group and 76% complete in
he Freestyle group. Follow-up was “active” and consisted of
irect contact with the patients or their families, by exam-
nation or telephone questionnaires. No governmental or
dministrative databases were used for this study.
urgical technique. The surgical technique and short-term
esults of this study have been previously reported (6).
riefly, all patients underwent total aortic root replacement
ith coronary artery reimplantation. No subcoronary im-
lantations were performed. The largest implantable pros-
hesis was always used in the aortic root. No reinforcement
echniques or synthetic material were used to support the
roximal or distal anastomosis. The coronaries were reim-
lanted in their respective sinuses. As the height and angle
etween the native porcine coronary ostia in Freestyle arostheses is different from that
n normal human anatomy, new
stia were fashioned to avoid
ension, torsion, or kinking of
he proximal coronary arteries.
omograft procurement. Two
ypes of homografts were used in
his study: “homovital” homografts
n  30) and antibiotic-sterilized
ryopreserved homografts (n 
6). Homovital homografts were
btained from heart transplanta-
ion recipients and immediately placed in sterile culture
edium with a low concentration antibiotic solution for
2 h at 4°C (1% penicillin/1% streptomycin). The median
ime from dissection to implantation in this study was 7
ays (range 1 to 30 days). The rest of the homografts were
arvested from routine post-mortem examination and pro-
essed at the Royal Brompton Tissue Bank. Homografts
ere dissected using sterile technique and sterilized using a
utrient antibiotic solution (Gaya 5 [8]), followed by
ryopreservation and storage at 130°C for up to 5 years
ntil use.
chocardiographic studies. Patients were prospectively
ollowed up with yearly echocardiographic examinations.
or logistical reasons, some patients were followed up with
chocardiographic examinations every 2 years. Transvalvular
ortic gradient using the continuity equation and the degree
f aortic insufficiency (AI) were evaluated (9). Indices of
entricular function were also evaluated, including left
entricular end-diastolic dimension, ejection fraction, and
eft ventricular mass regression. In an attempt to accurately
ssess the occurrence of “evolving” aortic valve dysfunction,
e defined it as AI 2/4 and/or transvalvular gradient 20
m Hg.
ymptomatic status and valve-related complications.
ymptomatic status of the patients on the basis of New
ork Heart Association (NYHA) functional classification at
ast follow-up was assessed and compared between groups.
ll valve-related complications as defined by the Society of
horacic Surgeons (10) were prospectively recorded.
tatistical analysis. Data are expressed as mean  SD or
edian (range) for continuous variables and as number
percentage) for categorical variables. Univariable analyses
ncluded the 2-tailed Wilcoxon rank sum or Student t test
or continuous variables and Fisher exact test for discrete
ariables. Univariable and multivariable Cox regression
odels were constructed to study determinants of survival.
ll variables in Table 1 were considered for the univariable
nalysis, and those with p  0.2 were included in the
ultivariable analysis. Survival analysis ( SD) was per-
ormed using the Kaplan-Meier method, and the log-rank
est was used to compare curves. Kaplan-Meier estimates of
he survival of all patients were compared with a matched
ohort for age, sex, and year of surgery using 1996 to 1998
Abbreviations
and Acronyms
AI  aortic insufficiency
AV  aortic valve
CI  confidence interval
EF  ejection fraction
HR  hazard ratio
NYHA  New York Heart
Associationnd 2005 to 2007 United Kingdom interim life tables (11).
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Freestyle Versus Homograft Aortic Root Replacement January 26, 2010:368–76To evaluate the change in echocardiographic values (left
entricular end-diastolic dimension, left ventricular ejection
raction, left ventricular mass) over time, mixed effects models
ere used to take into account the correlation between
epeated follow-up echocardiographic measurements (the
IXED procedure in SAS software version 9.1, SAS Insti-
ute, Cary, North Carolina). A fully parameterized mixed-
ffects model was built, including a coefficient for each time
oint for each group (baseline pre-operatively, post-operatively
efore discharge, and yearly thereafter). Overall, 62% of pa-
ients (103 of 166) had follow-up echocardiography every year
r every other year, and 81% (134 of 166) of patients had 3
ollow-up echocardiographic measures. Missing data points at
ach time point were considered to be missing at random for
his analysis. Variables with a p  0.05 were considered
tatistically significant.
esults
atient demographics. Pre-operative patient characteris-
atient Characteristics (n  166)Table 1 Patient Characteristics (n  166)
Variable
Homograft
(n  76)
Freestyle
(n  90) p Value
Age, yrs 64.1 9.2 66.0 8.2 0.2
55 12 10
56–65 22 26
66–75 30 40
75 12 14
Sex, male 49 (64) 61 (68) 0.6
BSA, m2 1.89 0.22 1.88 0.21 0.8
Cr clearance, ml/min* 72.6 (29.5–138.2) 70.2 (24.9–128.8) 0.7
LVEF, % 57.2 24.8 64.0 13.6 0.1
Aortic stenosis 51 (67) 63 (70) 0.5
Previous surgery 14 (18) 16 (18) 0.9
Comorbidities
Coronary artery disease 37 (49) 46 (51) 0.8
IDDM 5 (7) 2 (2) 0.3
NIDDM 6 (8) 4 (4) 0.3
Dyslipidemia 5 (7) 4 (4) 0.5
Renal failure† 9 (12) 11 (12) 0.8
Hypertension 24 (32) 19 (21) 0.2
Previous CVA 1 (1) 3 (3) 0.6
Previous TIA 8 (11) 5 (6) 0.4
Previous syncope 3 (4) 10 (11) 0.1
PVD 1 (1) 0 (0) 0.4
Infective endocarditis
Active 1 (1) 0 (0) 0.4
Treated 1 (1) 2 (2) 1.0
Valve pathology
Degenerative 51 (67) 57 (63) 1.0
Congenital 17 (22) 23 (26) 0.7
Rheumatic 8 (11) 10 (11) 1.0
alues are mean SD, n, n (%), or median (range). *Creatinine (Cr) clearance was calculated using
he Cockroft-Gault formula. †Renal failure was defined as an estimated Cr clearance50 ml/min.
BSA body surface area; CVA cerebrovascular accident; IDDM insulin-dependent diabetes
ellitus; LVEF  left ventricular ejection fraction; NIDDM  noninsulin-dependent diabetes
ellitus; PVD  peripheral vascular disease; TIA  transient ischemic attack.ics are presented in Table 1. Mean age of the patients was vimilar in both groups (Freestyle 66.0  8.2 years, and
omograft 64.1  9.2 years; p  0.2). In addition, age
istribution within each cohort was comparable between
roups (Table 1). The main indication for operation was
V stenosis (Freestyle 67%, and homografts 70%; p  0.5).
orty-four percent of Freestyle recipients and 47% of
omograft recipients underwent a concomitant procedure
p  0.8) (Table 2).
perative results. Operative results were similar between
roups (Table 2). Overall hospital mortality was 4.5% (4 of
0 patients) in the Freestyle group versus 5.3% (4 of 76
atients) in the homograft group (p  0.5). The hospital
ortality risk for isolated aortic root replacement was 0% in
perative and Post-Operative ResultsTable 2 Operative and Post-Operative Results
Variable
Homograft
(n  76)
Freestyle
(n  90) p Value
Overall hospital mortality 4 (5.3) 4 (4.5) 0.5
Isolated root replacement 1/40 (2.7) 0/50 (0)
Homografts
Homovital homografts 30 (39)
Cryopreserved homografts 46 (61)
Cross-clamp time, min 90 30 94 24 0.8
CPB time, min 131 37 139 42 0.2
Total blood loss, ml 600 (360–1,140) 600 (370–930) 1.0
Intubation time, h 10 (6–17) 11 (6–18) 0.6
Concomitant procedures 36 (47) 40 (44) 0.8
Coronary bypass 33 39
Replacement of TAA 3 1
Inotropes, h 0.8
24 36 (47) 41 (46)
24–48 15 (20) 20 (22)
48 25 (33) 29 (32)
Ventilation, h 0.7
24 63 (83) 72 (80)
24–48 0 (0) 3 (3)
48 13 (17) 15 (17)
Post-operative complications
Re-exploration 5 (7) 8 (9) 0.8
Sternal infection 2 (3) 4 (4) 0.7
Stroke 4 (5) 2 (2) 0.4
TIA 3 (4) 2 (2) 0.7
Acute renal failure 4 (5) 11 (12) 0.2
CVVH 1 (1) 8 (9) 0.04
Heart block 0 (0) 8 (9) 0.01
Atrial fibrillation 13 (17) 20 (22) 0.6
Valve-related complications
Endocarditis 1 2
Thromboembolic event 2 2
Major bleeding 0 0
Thrombosis 0 0
Medication at last follow-up
Warfarin 12/50 (24) 10/54 (18) 0.5
Statin 22/50 (52) 25/54 (46) 0.7
ACE inhibitor 27/50 (54) 23/54 (43) 0.4
Beta-blocker 20/50 (40) 15/54 (28) 0.2
alues are n (%), mean  SD, median (interquartile range), or n.
ACE  angiotensin-converting enzyme; CPB  cardiopulmonary bypass; CVVH  continuous
enovenous hemofiltration; TAA  thoracic aortic aneurysm; TIA  transient ischemic attack.
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January 26, 2010:368–76 Freestyle Versus Homograft Aortic Root Replacementhe Freestyle group and 2.7% in the homograft group. The
revalence of complications is listed in Table 2. No differ-
nces were observed between groups. Notably, 15 patients
mean age 69  6 years) suffered post-operative acute renal
ailure (8.5%). Of those, 7 had pre-operative renal failure
creatinine clearance 50 ml/min) and 5 were redo opera-
ions. Eight of the 15 patients had temporary hemofiltra-
ion, but none required long-term dialysis. In addition, 8
atients had heart block, 4 transient and 4 that required
ermanent pacemaker implantation (overall rate 2.4%).
ong-term survival. There were 4 early deaths and 17 late
eaths in the Freestyle group and 4 early and 15 late deaths
n the homograft group. Actuarial survival at 8 years was
0  5% in the Freestyle group versus 77  6% in the
omograft group (p 0.9) (Fig. 1). Expected survival for an
ge- and sex-matched United Kingdom population is 80%
t 8 years. Independent predictors of mortality were con-
omitant CABG (hazard ratio [HR]: 2.5 [95% confidence
nterval (CI): 1.3 to 4.9]; p  0.008), pre-operative NYHA
unctional class III or IV (HR: 2.1 [95% CI: 1.1 to 4.1]; p
.03), older age (HR: 1.8 [95% CI: 1.1 to 2.9]; p  0.02),
nd the need for an intra-aortic balloon pump at the time of
urgery (HR: 6.6 [95% CI: 3.0 to 14.3]; p 0.01) (Table 3).
f the 17 late deaths in the Freestyle group, 5 were cardiac,
were unrelated, and 7 were of unknown causes. Of the 15
ate deaths in the homograft group, 7 were cardiac, 6 were
nrelated, and 2 were of unknown causes. There were no
urvival differences between homovital and cryopreserved
omograft recipients.
ong-term freedom from reoperation. One patient in the
reestyle group underwent redo surgery for structural valve
eterioration manifested by cusp tear and aortic insufficiency
Figure 1 Actuarial Survival After Freestyle
Versus Homograft Root Replacement
Actuarial survival after Freestyle (blue) versus homograft (red) aortic root
replacement. The corresponding age- and sex-matched United Kingdom popula-
tion is plotted in black.t 9.5 years after surgery. No other Freestyle patients had an bndication for reoperation. In contrast, 6 patients in the
omograft group presented with a redo indication (Table 4).
hree of these patients were 55 years of age at the time of
nitial surgery, the other 3 ranged from 63 to 72 years of age
Table 4). Two of those 6 patients declined reoperation for
ersonal reasons and remained with aortic insufficiency and
ilating left ventricles. The remaining 4 patients showed
evere structural deterioration of the homografts with vary-
ng degrees of calcification in all of them. Of the 6 patients,
had homovital homografts (2 of 30 recipients) and 4 had
ryopreserved homografts (4 of 45 recipients). Actuarial
reedom from the need for reoperation at 8 years was
ignificantly higher after Freestyle root replacement versus
omograft root replacement (100% vs. 90  5%; p  0.02)
Fig. 2). Because of the low number of events, no indepen-
ent factors could be identified to predict the need for
eoperation or structural valve deterioration.
chocardiographic function. AORTIC VALVE. Actuarial
reedom from evolving aortic valve dysfunction defined as
I 2/4 and/or transvalvular gradient 20 mm Hg was
6  5% at 8 years in the Freestyle group versus 37  7%
n the homograft group (p  0.001) (Fig. 3). No differences
ere observed between both types of homografts used in
his study.
EFT VENTRICLE. Using mixed-effects models to assess
hanges in left ventricular function and dimensions over
ime, no differences were observed between both groups.
eft ventricular end-diastolic diameter decreased signifi-
antly after surgery in both groups, thereafter showing a
omparable marginal increase over the years (Fig. 4A).
imilarly, there was a significant decrease in left ventricular
ass after surgery in both groups, which remained stable for
p to 8 years of follow-up (Fig. 4B). Finally, left ventricular
jection fraction showed a significant increase up to 1 year
fter surgery and remained stable thereafter (Fig. 4C).
unctional assessment. Actuarial freedom from NYHA
unctional class III or IV was similar between both groups at
years: 95  3% (p  0.7) (Fig. 5).
alve-related complications. Two cases of infective endo-
arditis were diagnosed in the Freestyle group versus 1 in the
omograft group. Two patients in each group had thrombo-
mbolic events. In the Freestyle group, 1 patient had a
ransient ischemic attack during the post-operative period, and
he other had a stroke after an orthopedic procedure 6 years
ndependent Predictors ofong-Term Death After Aortic Root ReplacementTable 3 Ind pendent Predict rs ofLong-Term Death After Aortic Root Replacement
Hazard Ratio (95% CI) p Value
Age 1.8* (1.1–2.9) 0.02
NYHA functional class III or IV 2.1 (1.1–4.1) 0.03
IABP need at time of surgery 6.6 (3.0–14.3) 0.001
Concomitant CABG 2.5 (1.3–4.9) 0.008
Per 10-year age increase.
CABG  coronary artery bypass graft surgery; CI  confidence interval; IABP  intra-aortic
alloon pump; NYHA  New York Heart Association.
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Freestyle Versus Homograft Aortic Root Replacement January 26, 2010:368–76ost-operatively. Both cases in the homograft group were
ost-operative transient ischemic attacks.
Actuarial freedom from the composite end point of
ndocarditis, thromboembolism, thrombosis, and major
leeding was 96  3% at 8 years in the Freestyle group
ersus 96  2% in the homograft group (p  0.9) (Fig. 6).
iscussion
he major findings from this study are that use of the
edtronic Freestyle porcine bioprosthesis for total aortic
oot replacement is associated with a significantly lower rate
f structural valve deterioration and reoperation compared
ith homograft root replacement. These differences did not,
owever, translate into differences in survival between the 2
roups.
To date, the ideal choice for AV replacement remains
argely undetermined because of a lack of prospective
andomized studies. The present data suggest that the
reestyle bioprosthesis is a more durable substitute than
Figure 2 Actuarial Freedom From Reoperation After
Freestyle Versus Homograft Root Replacement
Actuarial freedom from need for reoperation ( SD)
after Freestyle (blue) versus homograft (red) aortic root replacement.
ndication, Operative Findings, and Outcomes of Patients RequiringTable 4 Indication, Operative Findings, and Outcomes of Patien
Initial Procedure Sex/Age (yrs) at Surgery Delay (yrs)
1 Homograft M/40 7 Severe
2 Homograft F/52 5 Severe
3 Homograft M/53 7 Mod AI
4 Homograft M/63 8.5 Severe
5 Homograft F/65 8 Severe
6 Homograft M/72 9 Mod–se
1 Freestyle F/63 9.5 Severe
I  aortic insufficiency; LV  left ventricular; Mod  moderate; MOF  multiorgan failure; MVR 
VR  tissue valve replacement.omografts when implanted as a freestanding total root.
ortic root replacement has been our favored surgical
echnique for patients with aortic valve or root disease. This
pproach is based on the knowledge that this technique
reserves the exact relationship between the different com-
onent parts of the valve mechanism, including the sinuses
f Valsalva and the sinotubular junction (Fig. 7). This
echnique can favorably influence patient survival (2), valve
urability (2,12), and possibly coronary flow (13). Other
roups have reported similar results with the use of the
reestyle prosthesis as a freestanding root, with overall
0-year freedom from structural deterioration and reopera-
ion of 96% and 92%, respectively (14). These results
ompare favorably with long-term outcomes after isolated
ortic valve replacement using a stented bioprosthesis
15–17). On the basis of our overall experience with total
oot replacement, we believe that all patients with aortic
alve or root disease benefit from this approach compared
ith stented bioprosthetic valve replacement, particularly
Figure 3 Actuarial Freedom From Aortic
Valve Dysfunction After Root Replacement
Actuarial freedom from “evolving” aortic valve dysfunction (aortic insufficiency
[AI] 2/4 and/or transprosthetic gradient [P] 20 mm Hg) after Freestyle
(blue) versus homograft (red) aortic root replacement.
o Surgeryequiring Redo Surgery
ation Findings Procedure Outcome
V dilation Dense aortic wall Ca MVR Alive
Cusp tear
Localized Ca
TVR Alive
dilation Heavy cusp Ca MVR Alive
Heavy cusp Ca
Cusp tear
TVR TR Died POD 1 (MOF)
N/A Declined Alive
I  symptoms N/A Declined Alive
Cusp tear TVR Died POD 24
anical valve replacement; N/A  not available; POD  post-operative day; TR  tricuspid repair;Redts R
Indic
AI  L
AI
 LV
AI
AI
vere A
AI
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January 26, 2010:368–76 Freestyle Versus Homograft Aortic Root Replacementatients with reduced left ventricular function. However,
hat needs to be evaluated in a prospective randomized trial
ooking at hemodynamic improvement, valve durability,
atient survival, and quality of life.
Mohammadi et al. (18) examined a cohort of 608 patients
ndergoing Freestyle implantation (78% subcoronary and
2% full roots) and reported a total of 10 cases of cusp tears
equiring reoperation at a median time of 8.7 years after
urgery. Notably, 9 of the 10 cases of cusp rupture occurred
Figure 5
Actuarial Freedom From NYHA Functional
Class III or IV After Freestyle Versus
Homograft Root Replacement
Actuarial freedom from New York Heart Association (NYHA) functional class
III or IV after Freestyle (blue) versus homograft (red) aortic root replacement.
Figure 6 Actuarial Freedom From Valve-Related Complications
After Freestyle Versus Homograft Root Replacement
Actuarial freedom from the composite end point of endocarditis, thromboembo-
lism, thrombosis, or major bleeding after Freestyle (blue) versus homograft
(red) aortic root replacement.Figure 4 Time-Dependent Changes After
Freestyle Versus Homograft Root Replacement
(A) Time-dependent changes in left ventricular end-diastolic dimension after
Freestyle versus homograft root replacement. (B) Time-dependent changes in
left ventricular mass after Freestyle versus homograft root replacement. (C)
Time-dependent changes in ejection fraction after Freestyle versus homograft
aortic root replacement. Blue  Freestyle; red  homograft.
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Freestyle Versus Homograft Aortic Root Replacement January 26, 2010:368–76fter subcoronary implantation with preservation of the
oncoronary sinus and were exclusively localized in the right
nd left coronary cusps. This finding suggests that total root
eplacement could be associated with less mechanical stress
n the cusps and might therefore lead to better long-term
urability of the valve. Continued close monitoring of these
atients is mandatory to evaluate this hypothesis. We are
urrently performing computational analysis studies of aor-
ic root biomechanics to define the role of different implan-
ation techniques on the tensile stresses and the aortic and
oronary flow patterns.
The increased incidence of homograft degeneration after
mplantation in this study mirrors that in other reports from
ifferent centers (19,20). Importantly, homograft degener-
tion is often accompanied by varying degrees of cusp and
all calcification (21), sometimes making reoperation a
ore difficult procedure (22), although in our experience
eoperation for homograft root replacement was associated
ith a similar mortality to first-time operation if reoperation
s not unduly delayed, resulting in multiorgan failure (23).
n this study, 1 patient undergoing reoperation died of
ultiorgan failure during the post-operative period. We
Figure 7 Rationale for Using Stentless Aortic Prostheses for Ao
Rationale for performing total aortic root replacement using a stentless aortic root
tural relationship between the different components of the valve mechanism. In ad
effective orifice area. These advantages could have an important impact on ventric
Rob Flewell.ave recently shown that the rate and extent of calcification aeasured by electron-beam computed tomography is sig-
ificantly higher in homograft roots than in Freestyle roots
p to 8 years after surgery (24). That is likely a consequence
f direct and indirect immune reactions elicited by the
ersistence of living cells and protein remnants on the
omograft cusps and wall. The rate of calcification observed
n that study was significantly faster during the first 3
ost-operative years. The slower rate of degeneration ob-
erved with Freestyle roots is possibly, in part, due to
re-treatment with alpha-oleic acid, which has been shown
o mitigate Freestyle wall calcification in animal studies
25). Nevertheless, a slow but steady increase in prosthetic
alcification was measured by electron-beam computed
omography up to 8 years after implantation (26). In a
ecent study of 9 cases of Freestyle reoperation, Butany et al.
27) reported 3 cases of significant calcification (grade 3 or
) and 3 cases of cusp tear at a median time of 5 years after
urgery, further emphasizing the importance of close patient
ollow-up. Interestingly, these 6 cases had all undergone
ubcoronary or root inclusion Freestyle implantation at
nitial surgery.
In the present study, both homovital homografts (n 30)
Valve Disease
tients with aortic valve disease. Replacing the entire root maintains the struc-
, it allows marked flexibility in oversizing the annulus thus providing a better
ynamics, long-term valve durability, and patient survival. Figure illustration byrtic
for pa
dition
ular dnd antibiotic-sterilized cryopreserved homografts (n  46)
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January 26, 2010:368–76 Freestyle Versus Homograft Aortic Root Replacementere used. No differences in survival, freedom from reop-
ration, or valve function were observed between the 2 types
f homografts. Nevertheless, the specific source and method
f preparation of the homografts could have an influence on
utcomes. Therefore, these results cannot be readily gener-
lized to commercially available homografts. Of the 6
atients requiring reoperation in the homograft group, 3
ccurred in patients 55 years of age at the time of surgery,
upporting the notion of accelerated tissue degeneration in
ounger patients. Nevertheless, no reoperations were re-
uired for that age group in the Freestyle cohort despite a
imilar age distribution between groups (Table 1).
It appears from the present data that the incidence of
volving valve failure for Freestyle bioprosthetic roots re-
ains low during the first 10 years, as evidenced by an
ctuarial freedom from evolving valve dysfunction defined as
I2/4 and/or transvalvular gradient20 mm Hg, of 86%
t 8 years. In contrast, freedom from evolving valve dys-
unction was found in only 37% of homograft recipients at
he same point. Nevertheless, the majority of these patients
ad grade 2/4 AI, which deteriorates at varying rates in
ome patients. This study raises important issues regarding
he role of homografts in patients with aortic valve disease.
omografts have traditionally been favored over isolated
alve replacement for cases of infectious endocarditis, small
ortic annuli, and for patients with associated root anoma-
ies. Except for patients with extensive infective endocarditis
nd root abscesses in whom homografts have a unique
enefit due to the mitral flange, the Freestyle bioprosthesis
ppears to offer the same advantages with the added benefit
f a lower rate of reoperations and early valve failure.
The number of children and young adults requiring aortic
alve surgery in developing countries is staggering and is
onstantly increasing because of improved access to health
are, better screening programs, and a persistent incidence
f rheumatic heart disease. Mechanical valve replacement
emains highly risky due to anticoagulation-related prob-
ems, and the Ross procedure remains a technically
omplex operation that requires the presence of ho-
ografts. The ready availability of bioprosthetic aortic
alves or Freestyle bioprostheses off the shelf in different
izes makes them particularly appealing in this context.
he rate of degeneration of both prostheses in young
atients requires further assessment. With improving
urgical expertise in the developing world, the presence of
durable valve substitute will be critical in these young
atients. Therefore, a similar study is mandated with a
ounger age group to confirm the current results or seek
ew alternatives. Recruitment of participating centers is
ow under way for the RAMSES (Randomized Au-
ograft Versus Mechanical Versus Stentless Study) in
oung patients, and we hope that will further help
etermine the ideal aortic valve substitute for a poten-
ially larger population of needy patients.
tudy limitations. Although clinical follow-up was 85%
omplete, overall echocardiographic follow-up was lowerue to patient-related factors including distance from hos-
ital, compliance with appointments, and lack of mobility.
linical follow-up was, however, directly obtained from the
atients to compensate for this potential bias, ensuring that
atients missing to echocardiographic follow-up were clin-
cally well. Mixed-effects models examining echocardio-
raphic measures over time are limited by the number of
issing data points. Although these were treated as missing
t random, this assumption may be invalid. Therefore,
urther data are required to validate our findings. The
umber of potential variables included in the multivariable
nalysis for predictors of mortality was dictated by the
umber of deaths. With longer follow-up and additional
vents, additional predictive factors may emerge. The length
f follow-up in this study does not represent “true long-
erm” follow-up (i.e., 20 years). Nevertheless, significant
ifferences were readily apparent between both groups. In
his study, we used an age cut-off of 40 years to perform this
peration. Similar studies are required for younger patients,
n particular to address the large cohorts of young patients in
eveloping countries requiring valve replacement. Finally,
lthough the study was randomized, patient medication was
ndividually prescribed according to current guidelines.
herefore, medication profiles differed slightly between
roups at last follow-up, which might have an undeter-
ined effect on outcomes.
onclusions
esults from this prospective randomized trial indicate
ignificantly better durability of the Medtronic Freestyle
ioprosthesis versus homografts after total aortic root re-
lacement. Despite the higher rate of structural valve
egeneration and reoperations in the homograft group,
verall survival between the 2 groups was nevertheless
imilar 9 years after surgery. These data have important
linical implications regarding the choice of bioprosthesis
or patients requiring aortic valve replacement, particularly
n developing countries where storage and availability of
omografts remains an important limitation.
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